1. Home
  2. AMGN vs SHOP Comparison

AMGN vs SHOP Comparison

Compare AMGN & SHOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMGN
  • SHOP
  • Stock Information
  • Founded
  • AMGN 1980
  • SHOP 2004
  • Country
  • AMGN United States
  • SHOP Canada
  • Employees
  • AMGN N/A
  • SHOP N/A
  • Industry
  • AMGN Biotechnology: Biological Products (No Diagnostic Substances)
  • SHOP Computer Software: Prepackaged Software
  • Sector
  • AMGN Health Care
  • SHOP Technology
  • Exchange
  • AMGN Nasdaq
  • SHOP Nasdaq
  • Market Cap
  • AMGN 141.6B
  • SHOP 148.1B
  • IPO Year
  • AMGN N/A
  • SHOP 2015
  • Fundamental
  • Price
  • AMGN $272.11
  • SHOP $103.31
  • Analyst Decision
  • AMGN Buy
  • SHOP Buy
  • Analyst Count
  • AMGN 22
  • SHOP 33
  • Target Price
  • AMGN $324.05
  • SHOP $100.57
  • AVG Volume (30 Days)
  • AMGN 3.5M
  • SHOP 5.5M
  • Earning Date
  • AMGN 02-04-2025
  • SHOP 02-11-2025
  • Dividend Yield
  • AMGN 3.50%
  • SHOP N/A
  • EPS Growth
  • AMGN N/A
  • SHOP N/A
  • EPS
  • AMGN 7.83
  • SHOP 1.06
  • Revenue
  • AMGN $32,534,000,000.00
  • SHOP $8,212,000,000.00
  • Revenue This Year
  • AMGN $20.07
  • SHOP $27.07
  • Revenue Next Year
  • AMGN $3.59
  • SHOP $22.86
  • P/E Ratio
  • AMGN $34.74
  • SHOP $97.72
  • Revenue Growth
  • AMGN 21.25
  • SHOP 23.47
  • 52 Week Low
  • AMGN $253.30
  • SHOP $48.56
  • 52 Week High
  • AMGN $346.85
  • SHOP $120.72
  • Technical
  • Relative Strength Index (RSI)
  • AMGN 54.19
  • SHOP 43.88
  • Support Level
  • AMGN $267.15
  • SHOP $99.05
  • Resistance Level
  • AMGN $272.82
  • SHOP $115.37
  • Average True Range (ATR)
  • AMGN 4.68
  • SHOP 3.29
  • MACD
  • AMGN 2.37
  • SHOP -0.91
  • Stochastic Oscillator
  • AMGN 75.60
  • SHOP 26.07

About AMGN Amgen Inc.

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

About SHOP Shopify Inc.

Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.

Share on Social Networks: